financetom
Business
financetom
/
Business
/
Plug Power Sees Strategic Reset to Drive Margin Recovery, Core Growth, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Plug Power Sees Strategic Reset to Drive Margin Recovery, Core Growth, RBC Says
Nov 11, 2025 9:02 AM

11:56 AM EST, 11/11/2025 (MT Newswires) -- Plug Power ( PLUG ) is advancing a strategic transition to a leaner, less capital-intensive model and reaffirmed its goal of achieving gross margin breakeven by Q4, RBC Capital Markets said in a Monday note.

According to the report, the company plans to monetize its New York electricity rights and suspend participation in the US Department of Energy loan program, moves expected to generate more than $275 million in liquidity and lift total unrestricted cash above $800 million.

Management reaffirmed its $700 million full-year revenue outlook, signaling a solid Q4, and said Plug is poised to achieve positive earnings before interest, taxes, depreciation, and amortization in H2 of 2026, according to the report.

Analysts view the actions as part of a broader pivot toward a simpler, higher-margin model focused on Plug's core material handling and electrolyzer segments, which have an $8 billion pipeline. Plug Power's ( PLUG ) Nov. 18 investor day is expected to outline plans for margin expansion, reduced cash burn, and long-term growth, analysts said.

RBC maintained its sector perform rating on the stock, with a price target of $1.50.

Shares of Plug Power ( PLUG ) were down more than 4% in recent Tuesday trading.

Price: 2.38, Change: -0.19, Percent Change: -7.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Beyond Acquires Zulily's Intellectual Property, Other Brand Assets
Beyond Acquires Zulily's Intellectual Property, Other Brand Assets
Mar 7, 2024
10:22 AM EST, 03/07/2024 (MT Newswires) -- Beyond (BYON) said Thursday it has acquired the intellectual property and other brand assets of flash sale and e-commerce retailer Zulily. The company bought the assets for $4.5 million plus acquisition-related costs. Beyond said the deal doesn't include Zulily's liabilities, liens, and debts. Beyond said it expects the new Zulily site to be...
Rising Loan Losses an Earnings Risk for Canadian Banks, CIBC Says
Rising Loan Losses an Earnings Risk for Canadian Banks, CIBC Says
Mar 7, 2024
10:24 AM EST, 03/07/2024 (MT Newswires) -- Rising loan losses could reduce earnings for Canadian banks, CIBC Capital Markets said on Thursday. Credit remains a wildcard, CIBC analyst Paul Holden said in a note to clients. Provisions for credit losses (PCLs) were higher than consensus for four of the six banks and impaired PCLs increased 18% quarter over quarter, Holden...
Lilly finds bacteria, other impurities in Mounjaro, Zepbound knockoffs
Lilly finds bacteria, other impurities in Mounjaro, Zepbound knockoffs
Mar 7, 2024
March 7 (Reuters) - Eli Lilly ( LLY ) said on Thursday it has found bacteria and high levels of impurities in products claiming to be compounded versions of tirzepatide, the active ingredient in its popular diabetes drug Mounjaro and weight loss treatment Zepbound. The U.S. drugmaker has sued several medical spas, weight-loss clinics and compounding pharmacies to stop them...
Mind Medicine Gets FDA Breakthrough for Anxiety Treatment, Sees $175 Million in Proceeds From Stock Offerings; Shares Jump
Mind Medicine Gets FDA Breakthrough for Anxiety Treatment, Sees $175 Million in Proceeds From Stock Offerings; Shares Jump
Mar 7, 2024
10:23 AM EST, 03/07/2024 (MT Newswires) -- Mind Medicine (MNMD) said Thursday the US Food and Drug Administration awarded breakthrough designation to its MM120 program for treating generalized anxiety disorder. The Phase 2b study for MM120 in GAD met its key secondary endpoint. The 12-week topline data showed sustained and statistically significant effectiveness through Week 12, achieving 65% clinical response...
Copyright 2023-2026 - www.financetom.com All Rights Reserved